menu search

Oric pharmaceuticals to participate in upcoming investor conferences

SOUTH SAN FRANCISCO and SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage ...

August 30, 2023, 8:30 pm

Oric pharmaceuticals to participate in upcoming investor conferences

SOUTH SAN FRANCISCO and SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage ...

August 30, 2023, 4:30 pm

Prelude therapeutics to participate in three healthcare investor conferences in september

WILMINGTON, Del., Aug. 29, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision ...

August 29, 2023, 12:30 pm

Ocean biomedical: some new targets, no clinical data. not for me

Ocean Biomedical is a biotech company focused on generating lead candidates for clinical development. They have programs in various therapeutic areas,...

August 28, 2023, 7:40 pm

oncology market's huge potential puts these stocks in focus

The oncology treatment market has been experiencing significant growth lately. Companies like Regeneron...

August 28, 2023, 9:46 am

Novocure shares plunge after ovarian cancer study failure

Shares of Novocure Ltd. NVCR, -0.77% dropped 37% premarket on Monday after the Swiss oncology company s...

August 28, 2023, 8:34 am

Iteos therapeutics and the tigit ticket to cancer's downfall

iTeos Therapeutics focuses on developing immuno-oncology treatments for cancer patients, with a focus o...

August 25, 2023, 3:55 pm

Inside tema etfs' new oncology etf (canc)

oncology treatment has witnessed remarkable progress due to the relentless efforts of pharmaceutical co...

August 25, 2023, 3:02 pm

Lybalvi: weighing in light, but tipping alkermes' scales

Alkermes to split neuroscience and oncology divisions; strong growth with drug Lybalvi highlighted. Fin...

August 24, 2023, 5:36 pm

Nanobiotix: at a crucial juncture for data

Nanobiotix is an oncology-focused biotech aiming for its first drug approval, with a tripled value sinc...

August 24, 2023, 8:40 am

Aptose to present at the h.c. wainwright 25th annual global investment conference

SAN DIEGO and TORONTO, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clin...

August 24, 2023, 7:30 am

Medigene ag to present at the 8th car-tcr summit in boston

Planegg/ Martins ried , August 22 , 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncolog...

August 22, 2023, 10:00 am

Down -15.56% in 4 weeks, here's why you should you buy the dip in pyxis oncology, inc. (pyxs)

Pyxis oncology, Inc. (PYXS) has become technically an oversold stock now, which implies exhaustion of t...

August 21, 2023, 11:17 am

Rosen, trusted investor counsel, firm encourages rain oncology inc. investors to secure counsel before important deadline in securities class action – rain

NEW YORK, Aug. 19, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain ...

August 19, 2023, 9:52 pm

Enliven therapeutics: preclinical company with interesting value proposition

Enliven Therapeutics, Inc. is a recently merged biopharma company focused on developing oncology candid...

August 18, 2023, 12:57 pm

Medicinova announces abstract regarding mn-166 (ibudilast) in glioblastoma accepted for presentation at the annual meeting of the society for neuro-oncology

LA JOLLA, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...

August 17, 2023, 11:00 pm

Spexis announces usd $2.5 million capital commitment to support the upcoming phase 3 colifin® studies

Ad hoc announcement pursuant to Art. 53 LR ALLSCHWIL, Switzerland, Aug. 14, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharm...

August 15, 2023, 5:15 am

Smoke evacuation device market size to hit usd 0.84 billion by 2032 at 9.54% cagr – report by market research future (mrfr)

Smoke Evacuation Device Market Trends and Insights by Component (Smoke Evacuation Filters [ULPA Filters, Charcoal Filters, In-line Filters, and Pre-fi...

August 14, 2023, 1:26 pm

Biocept cnside assay takes the spotlight at 2023 sno/asco cns cancer conference

Biocept Inc (NASDAQ:BIOC) said that its CNSide cerebrospinal fluid assay was featured in two oral presentations at the 2023 Society for Neuro-...

August 14, 2023, 8:40 am

Rosen, skilled investor counsel, encourages rain oncology inc. investors with losses to secure counsel before important deadline in securities class action – rain

NEW YORK, Aug. 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain ...

August 13, 2023, 2:03 pm


Search within

Pages Search Results: